N-of-One, Inc.

N-of-One, Inc. is a precision-medicine company specializing in the interpretation of molecular and genomic data, particularly for oncology. Its capabilities include clinical decision support and connecting molecular profiling results with relevant scientific and clinical evidence. Acquired by QIAGEN in 2019, N-of-One’s expertise complements QIAGEN’s broader molecular diagnostics and life-sciences portfolio.